Evidence map›Paper›PMID 36432106›Full record

ArticleMolecules (Basel, Switzerland)2022

Triptonoterpene, a Natural Product from

Haibo Wang, Yuanyuan Luo, Yaqi Hu, Xinyi Feng, Jun Feng, Zewen Chu, Shiya Ou, Xiaojun Dai, Xiaoqing Wang, Yanqing Liu

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Major bioactive metabolites derived fromFrontiers in pharmacology · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Haibo WangInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.ORCID 0000-0002-7549-5613
Yuanyuan LuoInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Yaqi HuInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Xinyi FengInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Jun FengDepartment of Oncology, Gaoyou Hospital of Traditional Chinese Medicine, Yangzhou 225600, China.
Zewen ChuInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Shiya OuInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Xiaojun DaiThe Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State Administration of Traditional Chinese Medicine, Yangzhou 225001, China.
Xiaoqing WangDepartment of Oncology, Gaoyou Hospital of Traditional Chinese Medicine, Yangzhou 225600, China.
Yanqing LiuInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
State Administration of Traditional Chinese Medicine of the People's Republic of China · CNAnyang Hospital of Traditional Chinese Medicine · CN

Funding

National Natural Science Foundation of China 82104946, 82274603Natural Science Foundation of Jiangsu Province BK20210817The Traditional Chinese Medicine Science and Technology Development Project of Jiangsu Province QN202008
6 · The paper itself

Abstract

Cancer is one of the greatest threats to human health. Gastric cancer (GC) is the fifth most common malignant tumor in the world. Invasion and metastasis are the major difficulties in the treatment of GC. Herbal medicines and their extracts have a lengthy history of being used to treat tumors in China. The anti-tumoral effects of the natural products derived from herbs have received a great deal of attention. Our previous studies have shown that the traditional Chinese herb

Indexed as

Biological ProductsCelastrusStomach NeoplasmsCell Line, TumorEpithelial-Mesenchymal TransitionHumansNeoplastic ProcessesPlant ExtractsBiological ProductsPlant ExtractsCelastrus orbiculatus Thunbgastric cancermetastasisnatural producttriptonoterpene

Identifiers

PMID36432106
PMCPMC9693919
OpenAlexW4309455252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.